Positive context积极背景
Stocks股票 / Health Care / DNA
Ginkgo Bioworks Holdings Inc · Health Care
DNA US listed · USD美股 · 美元
Health Care
Russell 2000罗素2000
Speculative / unprofitable投机／未盈利
$10.66
+$0.41 · +4.00%
52w low52周低 $5.09high高 $16.73
Extended — wait for a pullback过度拉伸 — 等待回撤
Trend intact — hold. Late in the cycle, so don't add here; a pullback is due.趋势完好——持有。已处周期晚期，此处不宜加仓；回调即将到来。
As of 2026-09-27截至 2026-09-27
Company intelligence公司情报
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考；使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动，请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Pressure context压力背景
History mode历史模式
Context only仅供参考 · not a signal or recommendation不构成信号或建议
Narrative claims may await line-level citation; verify in the transcript.叙述性内容可能仍待逐行引用，请在电话会原文中核对。
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-09-27
Momentum (RSI 14)动量（RSI 14）
74
Overbought超买区域
vs 50-day average相对50日均线
+39.2% above上方
Uptrend intact趋势完好
vs 200-day average相对200日均线
+29.1% above上方
Long trend up长期向上
Volatility波动率
62th percentile第62百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
Financials财务数据
fiscal years财年Revenue营业收入
$170.2M2025
20212025
5-yr growth5年复合增速 -14.2%
Earnings per share每股收益
$-5.642025
20212025
Free cash flow自由现金流
-$178.7M2025
20212025
Operating margin营业利润率
-185.3%
Net margin净利率
-183.9%
FCF margin自由现金流利润率
-100.5%
Balance-sheet quality财务体质 2/7
Return on equity股本回报率 -62%
Watch关注
Leverage杠杆
Current ratio流动比率4.92
Capital allocation资本配置
Stock-based comp股权薪酬$81.5M
Share count change (1y)股数变化（1年）+7.1%
Debt coming due到期债务
SEC filingsSEC 文件Its filings are available, but they do not break debt down by the year it comes due — every bucket below is unreported.已获取该公司的 SEC 文件，但文件中未按到期年度拆分债务 —— 以下各区间均未披露。
Next 12 months未来12个月
not reported未披露
Year 2第2年
not reported未披露
Year 3第3年
not reported未披露
Year 4第4年
not reported未披露
Year 5第5年
not reported未披露
After year 55年以后
not reported未披露
Not every company reports a year-by-year schedule. Nothing is being estimated in its place.并非所有公司都会披露逐年到期安排；此处不作任何估算替代。
Cash reported at 2025-12-31: $167202000.截至 2025-12-31 披露的现金：$167202000。 At the cash-burn pace reported over 2025-01-01 to 2025-12-31, that cash represented about 11.2 months. This scenario excludes debt payments and future financing.按 2025-01-01 至 2025-12-31 期间披露的现金消耗速度，该现金约对应 11.2 个月。此情景不包括债务偿还与未来融资。
Capital-need coverage is partial; incomplete or incompatible filing inputs are not combined.资本需求覆盖信息不完整；不会合并不完整或不兼容的报告数据。
Any available cash-flow scenario is context only. Missing or incompatible inputs are not replaced with zero or a financing forecast.可用现金流情景仅供参考；缺失或不兼容的输入不以零值或融资预测替代。
Sources and cash-flow calculation来源与现金流计算
Annual period年度区间 2025-01-01 — 2025-12-31 · USD · 10-K · 0001628280-26-012346 · Filed提交日期 2026-02-26.
Cache acquired缓存获取时间: 2026-09-23T08:03:10.513569+00:00 · Evaluated as of评估截至 2026-09-28.
- Reported operating cash flow已披露经营活动现金流: $-171059000
- Reported equipment spending (capex outflow)已披露设备支出（资本开支流出）: $7665000
- Derived free cash flow (operating cash flow minus capex)计算所得自由现金流（经营现金流减资本开支）: $-178724000
Cash is the reported balance at period end. The runway scenario holds this annual cash-flow pace constant and excludes debt payments, restricted-cash adjustments and future financing.现金为期末已披露余额。现金跑道情景假设本年度现金流速度保持不变，不包括债务偿还、受限现金调整与未来融资。
Research context only — reported figures from SEC filings, not a rating, a signal or investment advice.仅供研究参考 — 数据摘自 SEC 文件披露口径，不构成评级、信号或投资建议。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
News新闻
2 recent stories — mixed2 篇最新报道，多空参半
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
DNA weekly MACD crossed upDNA 周线MACD上穿
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$3.5M net (0 buyers, 4 sellers)-$3.5M 净值（0 买家，4 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| Viking Global (Halvorsen) | B | Holding持有 | 0.1% | 2026-06-30 |
| Casdin Capital | C | Holding持有 | 0.0% | 2026-06-30 |
Signal history信号历史
engine events引擎事件
UNCONFIRMED TURN → UPTREND未确认转向 → 上涨趋势
HOLD. The weekly (investor-cycle) momentum just crossed UP while price holds its 10-day average — the start of a new multi-month up-leg. A daily-overbought print here is the launch thrust, not a top, so this is a HOLD / ride, not a take-profit. The daily can still dip to its 10-day average (normal) — but the bigger investor cycle is early, with room left持有。周线（投资者周期）动量刚刚向上交叉，且价格守住 10 日均线——这是新的多月上行段的起点。此处日线超买只是启动推力、并非见顶，因此应持有 / 顺势，而非止盈。日线仍可能回踩 10 日均线（属正常）——但更大的投资者周期尚处早期，仍有空间
Sep 25, 2026
DNA weekly MACD crossed upDNA 周线MACD上穿
The weekly MACD histogram turned positive — the slower, less-whippy momentum read.周线MACD柱状图转正 — 更慢、更少来回的动量信号。
Sep 24, 2026
BUY ZONE → UPTREND买入区 → 上涨趋势
HOLD持有
Sep 24, 2026
DNA took relative-strength leadershipDNA 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $10.25.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$10.25。
Sep 24, 2026
DNA RSI reached overboughtDNA RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $10.25.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$10.25。
Sep 22, 2026
DNA reclaimed its 200-day averageDNA 收复200日均线
Price closed back above the 200-day moving average — the classic bull dividing line. $9.37.收盘重回200日均线 — 经典的多头分界线。$9.37。
Sep 22, 2026
DNA RSI reached overboughtDNA RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $9.37.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$9.37。
Sep 14, 2026
DNA StochRSI turned up from oversoldDNA StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $7.01.StochRSI重回20上方 — 下行动量趋缓的最早预警。$7.01。
Sep 9, 2026
NEARING A LOW → UNCONFIRMED TURN接近低点 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Sep 1, 2026
DOWNTREND → NEARING A LOW下跌趋势 → 接近低点
GET READY准备
Aug 31, 2026
Death cross on DNADNA 死叉
The 50-day average crossed below the 200-day — a slow, widely-watched bearish trend signal. $6.81.50日均线下穿200日均线 — 一个滞后但广受关注的看空趋势信号。$6.81。
Showing the last 15 of显示最近15条，共 178 signals条信号
Company profile公司档案
Watch items — what could change the story关注项 — 可能改变故事的因素
- Receivables stretch
Recent news最新动态
AI-Driven Innovation Reshapes Vaccine Adjuvant Discovery as Investment Surges Across Public and Private Sectors
GlobeNewswire Inc. · 2026-09-24
Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Zacks Investment Research · 2026-09-23
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +35.3% | +1.3% |
| 1 Month近1月 | +47.4% | +0.9% |
| 3 Months近3月 | +4.0% | +6.1% |
| 6 Months近6月 | +79.8% | +22.3% |
| Year to date年初至今 | +22.5% | +13.8% |
| 1 Year近1年 | -5.2% | +18.5% |
Trading information交易信息
Volatility rank波动率分位
62th pctile
EPS (trailing)每股收益
$-5.38
Off 52-week high距52周高点
-34.0%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|
| Revenue营业收入 | $314M | $478M | $251M | $227M | $170M |
| EPS每股收益 | $-1.39 | $-1.25 | $-0.46 | $-10.54 | $-5.64 |
| Free cash flow自由现金流 | $-310M | $-304M | $-336M | $-382M | $-179M |
| Gross margin毛利率 | — | — | — | — | — |
| Net margin净利率 | -583.1% | -440.6% | -355.1% | -240.9% | -183.8% |
| FCF margin自由现金流利润率 | -98.9% | -63.7% | -133.7% | -168.3% | -105.0% |
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$170M
Net income净利润
$-313M
Operating cash flow经营现金流
$-171M
Total assets总资产
$1.1B
Shareholder equity股东权益
$509M
Shares outstanding总股本
0.06B
Returns & growth回报与增长
Return on equity股本回报率
-61.5%
Return on assets资产回报率
-28.0%
Asset growth资产增速
-18.7%
Accounting quality checks会计质量检查
- Earnings quality: accruals trending up over 5 fiscal years — earnings increasingly not cash-backed盈利质量：应计利润在 5 个财年间走高——盈利的现金支撑减弱
- Working capital: inventory & receivables lean vs sales营运资本：存货与应收相对销售保持精简
- Capital discipline: investment near the peer median资本纪律：投资力度接近同业中位
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
74
RSI (2-day)RSI（2日）
88
vs 20-day average相对20日均线
+39.8%
vs 50-day average相对50日均线
+39.2%
vs 200-day average相对200日均线
+29.1%
Golden cross (50>200)金叉（50>200）
not in effect未生效
MACDMACD
above signal位于信号线上方
Timeframe alignment多周期共振
Daily日线
momentum up动能向上
3-day3日线
momentum up — fresh upturn动能向上——刚刚转强
Weekly周线
momentum up — fresh upturn动能向上——刚刚转强
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range width percentile波幅宽度分位
90/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| Viking Global (Halvorsen) | B | Holding持有 | 0.1% | $35M |
| Casdin Capital | C | Holding持有 | 0.0% | $361,646 |
Fund positioning基金持仓概览
Tracked funds in the name持有该股的跟踪基金
2
Buying vs selling买入vs卖出
0 : 0
Quarterly trend季度趋势
{'direction': 'accumulating', 'n_quarters': 8, 'holders_first': 2, 'holders_last': 2, 'holders_delta': 0, 'value_change_pct': 21.6, 'from_period': '2024-09-30', 'to_period': '2026-06-30', 'available_on': '2026-08-15', 'available_on_first': '2024-11-15', 'holders_series': [2, 2, 2, 2, 2, 2, 2, 2]}{'direction': 'accumulating', 'n_quarters': 8, 'holders_first': 2, 'holders_last': 2, 'holders_delta': 0, 'value_change_pct': 21.6, 'from_period': '2024-09-30', 'to_period': '2026-06-30', 'available_on': '2026-08-15', 'available_on_first': '2024-11-15', 'holders_series': [2, 2, 2, 2, 2, 2, 2, 2]}
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$3.5M
Insider buyers vs sellers内部人买家vs卖家
0 : 4
Recent fund flows近期基金流向
ROBO Global Artificial IntelligenceROBO Global Artificial Intelligence
accumulating持续增持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。